The Journal of Organic Chemistry
Article
reflux. After 12 h, the dry toluene (150 mL) and 3c (408 mg, 1 mmol)
were added, and the resulting mixture was refluxed for another 48 h.
The reaction mixture was then cooled down to room temperature, and
water (1 mL) was added slowly. The solvent was removed under
reduced pressure, and the residue was dissolved in CH2Cl2 (200 mL).
The organic solution was washed with brine (3 × 50 mL) and dried
over anhydrous MgSO4. After removal of solvent, the residue was
chromatographed on a silica gel column using a mixture of petroleum
ether and ethyl acetate (v:v = 1:1) as the mobile phase to give pure 5c
(182 mg, 25%) as a white solid: mp 279−280 °C; IR (KBr) ν 1574,
1537, 1470, 1407, 1209 cm−1; 1H NMR (300 MHz, CDCl3) δ 8.55 (s,
6H), 7.02 (s, 6H), 4.22 (q, J = 6.9 Hz, 12H), 1.29 (t, J = 6.9 Hz, 18H);
13C NMR (75 MHz, CDCl3) δ 161.6, 158.2, 100.1, 43.0, 13.3; MS
J = 8.0 Hz), 7.83 (d, 3H, J = 8.0 Hz), 7.69 (d, 3H, J = 7.6 Hz), 7.54−
7.46 (m, 6H), 7.37 (d, 3H, J = 6.4 Hz), 7.32−7.27 (m, 6H), 6.79 (d,
3H, J = 7.6 Hz), 6.75 (d, 3H, J = 8.0 Hz,), 6.56 (s, 3H), 5.95 (s, 6H),
3.36 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 162.0, 159.0, 156.2,
155.1, 138.2, 133.8, 133.7, 131.3, 128.8, 127.5, 126.1, 125.7, 125.3,
124.7, 123.3, 112.9, 112.1, 92.2, 18.2, 34.9; MS (MALDI-TOF) m/z
1019 [M + H]+. Anal. Calcd. for C63H51N15: C, 74.32; H, 5.05; N,
20.63. Found: C, 73.93; H, 5.10; N, 20.25.
5j. Compound 5j was obtained as a white powder (290 mg, 35%):
mp 226−227 °C; IR (KBr) ν 3037, 1599, 1566, 1526, 1436, 1220, 843
1
cm−1; H NMR (400 MHz, CDCl3) δ 8.58 (s, 3H), 8.46 (d, 3H, J =
8.8 Hz), 8.16 (m, 6H), 8.10 (d, 3H, J = 9.2 Hz), 8.02−7.95 (m, 15H),
7.16 (t, 3H, J = 7.8 Hz), 6.71 (d, 3H, J = 8.0 Hz), 6.65 (d, 3H, J = 8.0
Hz,), 6.51 (s, 3H), 6.20 (s, 6H), 3.37 (s, 9H); 13C NMR (100 MHz,
CDCl3) δ 162.2, 162.1, 158.8, 156.3, 155.0, 138.2, 132.0, 131.4, 130.9,
130.5, 128.7, 127.6, 127.4, 127.1, 126.1, 125.9, 125.14, 125.07, 124.95,
124.9, 124.6, 123.0, 113.1, 112.0, 92.4, 48.4, 35.0; MS (MALDI-TOF),
neg m/z 1238 [M − H]−. Anal. Calcd for C81H57N15: C, 78.43; H,
4.63; N, 16.94. Found: C, 78.17; H, 4.70; N, 16.75.
(MALDI-TOF) m/z 727 [M + H]+. Anal. Calcd for C36H42N18: C,
59.49; H, 5.82; N, 34.69. Found: C, 59.35; H, 5.78; N, 34.83. Slow
evaporation of the solvent from a mixture of petroleum ether and ethyl
acetate gave a single crystal suitable for X-ray diffraction analysis.
General Procedure for the Synthesis of Azacalix[3]pyridine-
[3]pyrimidines 5e−5o. Under argon protection, a mixture of 8a−8k
(2 mmol) and Pd2(dba)3 (138 mg, 0.15 mmol), dppp (123 mg, 0.3
mmol), and sodium t-butoxide (288 mg, 3 mmol) in anhydrous 1,4-
dioxane (200 mL) was refluxed for 3 h. The reaction mixture was
cooled down to room temperature and filtered through a Celite pad.
The filtrate was concentrated under vacuum, and the residue was
dissolved in dichloromethane (100 mL) and washed with brine (3 ×
25 mL). The aqueous phase was re-extracted with dichloromethane (3
× 20 mL), and the combined organic phase was dried over anhydrous
MgSO4. After removal of solvent, the residue was chromatographed on
a silica gel column using a mixture of petroleum ether and ethyl acetate
(v:v = 1:1) as the mobile phase to give products 5e−5o.
5k. Compound 5k was obtained as a white solid (249 mg, 41%):
mp 280−282 °C; IR (KBr) ν 3030, 2956, 1601, 1566, 1526, 1477,
1
1435, 1419, 1265, 1233, 1187, 1161, 982 cm−1; H NMR (400 MHz,
CDCl3) δ 8.69 (s, 3H), 7.41 (t, 3H, J = 8.0 Hz), 7.30−7.17 (m, 15H),
6.79 (d, 3H, J = 8.0 Hz), 6.71 (d, 3H, J = 8.0 Hz,), 6.52 (s, 3H), 4.44
(t, 6H, J = 7.6 Hz), 3.66 (s, 9H), 3.04 (t, 6H, J = 7.8 Hz); 13C NMR
(100 MHz, CDCl3) δ 162.5, 161.9, 159.2, 156.2, 155.8, 139.5, 137.4,
129.0, 128.4, 126.2, 111.7, 111.3, 93.0, 49.0, 35.2, 34.7; MS (MALDI-
TOF) m/z 910 [M + H]+. Anal. Calcd. for C54H51N15: C, 71.27; H,
5.65; N, 23.09. Found: C, 70.95; H, 5.79; N, 22.75.
5l. Compound 5l was obtained as a colorless block (201 mg, 32%):
mp 182−184 °C; IR (KBr) ν 2940, 2227, 1601, 1567, 1527, 1440,
5e. Compound 5e was obtained as colorless needles (229 mg,
1
54%): mp > 300 °C; IR (KBr) ν 1601, 1565, 1525, 1429 cm−1; H
1
1220, 1166, 983, 964 cm−1; H NMR (400 MHz, CDCl3) δ 8.56 (s,
NMR (300 MHz, CDCl3) δ 8.61 (d, J = 0.6 Hz, 3H), 7.38 (t, J = 8.1
Hz, 3H), 6.77 (d, J = 8.1 Hz, 6H), 6.47 (s, 3H), 3.57 (s, 18H); 13C
NMR (75 MHz, CDCl3) δ 162.1, 158.8, 156.2, 137.8, 111.6, 92.3,
34.9; MS (MALDI-TOF) m/z 662 [M + Na]+, 640 [M + H]+. Anal.
Calcd. for C33H33N15: C, 61.96; H, 5.20; N, 32.84. Found: C, 61.99; H,
5.20; N, 32.80.
5f. Compound 5f was obtained as a colorless block (263 mg, 55%):
mp > 300 °C; IR (KBr) ν 1600, 1566, 1523, 1471, 1425, 1224, 1157
cm−1; 1H NMR (400 MHz, CDCl3) δ 8.61 (s, 3H), 7.40 (t, 3H, J = 7.8
Hz), 6.80−6.77 (m, 6H), 6.49 (s, 3H), 6.01−5.91 (m, 3H), 5.16 (dd,
3H, J1 = 17.2 Hz, J2 = 1.6 Hz), 5.06 (dd, 3H, J = 10.2 Hz, J = 1.4 Hz),
5.82 (d, 6H, J = 5.6 Hz), 3.56 (s, 9H); 13C NMR (100 MHz, CDCl3) δ
162.5, 161.8, 159.1, 156.2, 155.4, 137.7, 134.4, 116.6, 111.8, 111.6,
92.9, 49.4, 34.8; MS (MALDI-TOF) m/z 719 [M + H]+. Anal. Calcd.
for C39H39N15: C, 65.25; H, 5.48; N, 29.27. Found: C, 65.23; H, 5.54;
N, 29.16.
3H),7.54−7.42 (m, 15H), 6.81−6.79 (m, 6H), 6.57 (s, 3H), 5.47 (s,
6H), 3.44 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 162.6, 161.7,
159.2, 156.3, 155.2, 144.8, 137.9, 132.2, 128.4, 118.9, 111.9, 111.6,
110.8, 92.9, 50.0, 34.7; MS (MALDI-TOF) m/z 943 [M + H]+. Anal.
Calcd. for C54H42N18: C, 68.78; H, 4.49; N, 26.74. Found: C, 68.78; H,
4.57; N, 26.46. Slow diffusion of benzene into CCl4 solution gave a
single crystal suitable for X-ray diffraction analysis.
5m. Compound 5m was obtained as a white powder (294 mg,
46%): mp 151−152 °C; IR (KBr) ν 2948, 2936, 2834,1600, 1565,
1525, 1512, 1436, 1425, 1396, 1246, 1218, 1160 cm−1; 1H NMR (400
MHz, CDCl3) δ 8.61 (d, 3H, J = 0.8 Hz), 7.35−7.30 (m, 9H), 6.77−
6.72 (m, 9H), 6.68 (d, 3H, J = 7.6 Hz), 6.47 (s, 3H), 6.36 (s, 6H), 3.73
(s, 9H), 3.52 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 162.4, 161.9,
159.0, 158.6, 156.1, 155.5, 137.8, 131.0, 129.4, 113.6, 112.0, 111.6,
93.2, 55.3, 49.7, 34.9; MS (MALDI-TOF) m/z 958 [M + H]+. Anal.
Calcd. for C54H51N15O3: C, 67.70; H, 5.37; N, 21.93.Found: C, 67.92;
H, 5.49; N, 21.69.
5n. Compound 5n was obtained as a colorless block (244 mg,
46%): mp 282−283 °C; IR (KBr) ν 1598, 1567, 1525, 1475, 1444,
1421, 1212, 1157 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.60 (s, 3H),
7.43 (t, 3H, 8.0 Hz), 6.80(d, 6H, J = 8.0 Hz), 6.52 (s, 3H), 6.00−5.90
(m, 3H), 5.13 (dd, 6H, J = 17.0 Hz, J = 1.4 Hz), 5.05 (dd, J = 10.2 Hz,
J = 1.4 Hz), 4.79 (d, 12H, J = 4 Hz), 3.73 (s, 9H), 3.52 (s, 9H); 13C
NMR (100 MHz, CDCl3) δ 162.0, 159.3, 155.5, 137.7, 134.4, 116.6,
111.9, 93.2, 49.3; MS (MALDI-TOF) m/z 796 [M + H]+. Anal. Calcd
for C45H45N15: C, 67.90; H, 5.70; N, 26.40. Found: C, 67.64; H, 5.60;
N, 26.24. Slow evaporation of the solvent from a mixture of petroleum
ether and ethyl acetate gave a single crystal suitable for X-ray
diffraction analysis.
5g. Compound 5g was obtained as a white solid (301 mg, 52%):
mp 161−162 °C; IR (KBr) ν 1600, 1566, 1526, 1437, 1220, 1158
1
cm−1; H NMR (400 MHz, CDCl3) δ 8.59 (s, 3H), 7.37−7.32 (m,
9H), 7.23−7.16 (m, 9H), 6.74 (d, 3H, J = 8.0 Hz), 6.69 (d, 3H, J = 7.6
Hz), 6.51 (s, 3H), 5.43 (s, 6H), 3.49 (s, 9H); 13C NMR (100 MHz,
CDCl3) δ 162.5, 162.0, 159.1, 156.2, 155.5, 139.0, 137.8, 128.3, 127.9,
126.9, 111.9, 111.6, 93.1, 50.3, 34.8; MS (MALDI-TOF) m/z 869 [M
+ H]+. Anal. Calcd. for C51H45N15: C, 70.57; H, 5.23; N, 24.2. Found:
C, 70.44; H, 5.32; N, 23.88.
5h. Compound 5h was obtained as a white solid (292 mg, 43%):
mp 168−169 °C; IR (KBr) ν 3054, 1600, 1565, 1526, 1429, 1400,
1
1220 cm−1; H NMR (400 MHz, CDCl3) δ 8.61 (s, 3H), 7.79−7.70
(m, 12H), 7.55 (dd, 3H, J = 8.4 Hz, J = 1.6 Hz), 7.43−7.38 (m, 6H),
7.34 (t, 3H, 8.0 Hz), 6.77−6.74 (m, 6H), 6.57 (s, 3H), 5.60 (s, 6H),
3.51 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 162.6, 162.1, 159.1,
156.3, 155.5, 137.8, 136.6, 133.4, 132.7, 127.9, 127.7, 127.6, 126.8,
126.3, 125.9, 125.5, 112.1, 111.7, 93.0, 50.5, 34.8; MS (MALDI-TOF)
m/z 1019 [M + H]+. Anal. Calcd. for C63H51 shyN15: C, 74.32; H,
5.05; N, 20.63. Found: C, 74.08; H, 5.04; N, 20.59.
5o. Compound 5o was obtained as a white powder (244 mg, 61%):
mp 268−269 °C; IR (KBr) ν 3033, 1598, 1565, 1525, 1474, 1440,
1
1278, 1206, 1162 cm−1; H NMR (400 MHz, d6-DMSO) δ 8.45 (s,
3H), 7.69 (t, 3H, J = 7.6 Hz), 7.18−7.09 (m, 36H), 6.48 (s, 3H), 5.30
(s, 12H); 13C NMR (100 MHz, CDCl3) δ 162.3, 159.4, 138.8, 137.5,
128.3, 127.7, 126.9, 111.9, 93.4, 50.1; MS (MALDI-TOF) m/z 1096
[M + H]+. Anal. Calcd for C69H57N15: C, 75.59; H, 5.24; N, 19.16.
Found: C, 75.19; H, 5.31; N, 19.16. Slow evaporation of the solvent
5i. Compound 5i was obtained as a white solid (312 mg, 46%): mp
268−269 °C; IR (KBr) ν 3046, 1599, 1567, 1525, 1474, 1437, 1397,
1221 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.55 (s, 3H), 8.17 (d, 3H,
3570
dx.doi.org/10.1021/jo5003714 | J. Org. Chem. 2014, 79, 3559−3571